Telomerase and its extracurricular activities

• Autorzy: Jaiswal R K , Yadava P. K.
• Języki publikacji: EN

Abstrakty

EN

The classical activity of telomerase is to synthesize telomeric repeats and thus maintain telomere length, which in turn ensures chromosome stability and cellular proliferation. However, there is growing evidence that implicates telomerase in many other functions that are independent of TERC being used as its template. Telomerase has an RNA-dependent RNA polymerase (RdRP) activity in the mitochondria. Other than viral RdRPs, it is the only RNA-dependent RNA polymerase that has been identified in mammals. It also plays a role in the Wnt signaling pathway by acting as a transcriptional modulator. Telomerase acts as a reverse transcriptase independent of its core subunit, TERC. Studies indicate that telomerase is also involved in apoptosis and DNA repair.

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2013
• Tom: 18
• Numer: 4
• Opis fizyczny: p.538-554,fig.,ref.

Twórcy

autor

Jaiswal R K

• Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India

autor

Yadava P. K.

• Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India

Bibliografia

• 1. Olovnikov, A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41 (1973) 181-190.
• 2. Watson, J.D. Origin of concatemeric T7 DNA. Nat. New Biol. 239 (1972) 197-201.
• 3. Palm, W. and de Lange, T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42 (2008) 301-334.
• 4. Liu, D., Safari, A., O’Connor, M., Chan, D.W., Laegeler, A., Qin, J. and Songyang, Z. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell. Biol. 6 (2004) 673‐680.
• 5. Houghtaling, B.R., Cuttonaro, L., Chang, W. and Smith, S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14 (2004) 1621‐1631.
• 6. Ye, J.Z., Hockemeyer, D., Krutchinsky, A.N., Loayza, D., Hooper, S., Chait, B.T. and De Lange, T. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18 (2004) 1649‐1654.
• 7. De Lange, T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110.
• 8. Henderson, E.R and Blackburn, E.H. An overhanging 39 terminus is a conserved feature of telomeres. Mol. Cell. Biol. 9 (1989) 345-348.
• 9. Makarov, V.L., Hirose, Y. and Langmore J.P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88 (1997) 657-666.
• 10. McElligott, R. and Wellinger, R.J. The terminal DNA structure of mammalian chromosomes. EMBO J. 16 (1997) 3705-3714.
• 11. Woodring, E.W., Valerie. M.T., Kenneth, E.H., Stephen, D.L., and Jerry, W.S. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11 (1997) 2801-2809.
• 12. Greider, C.W. and Blackburn, E.H. Identification of a specific telomere terminal transferase enzyme with two kinds of primer specificity. Cell 51 (1985) 405-413.
• 13. Kim. N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015.
• 14. Chang, J.T., Chen, Y.L., Yang, H.T., Chen, C.Y. and Cheng, A.J. Differential regulation of telomerase activity by six telomerase subunits. Eur. J. Biochem. 269 (2002) 3442-3450.
• 15. Greider, C.W. and Blackburn, E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 (1989) 331-337.
• 16. Blasco, M.A., Funk, W., Villeponteau, B. and Greider, C.W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269 (1995) 1267-1270.
• 17. Feng, J., Funk, WD., Wang. S.S., Weinrich, S.L., Avilion, A.A., Chiu, C.P, Adams R.R, Chang, E., Allsopp, R.C., Yu, J., Le, S., West, M.D., Harley, C.B., Andrews, W.H., Greider, C.W. and Villeponteau, B. The RNA component of human telomerase. Science 269 (1995) 1236-1241.
• 18. Chen, J.L. and Greider, C.W. Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. EMBO J. 22 (2003) 304-314.
• 19. Lai, C.K., Miller, M.C. and Collins, K. Roles for RNA in telomerase nucleotide and repeat addition processivity. Mol. Cell. 11 (2003) 1673-1683.
• 20. Chen, J.L., Blasco, M.A. and Greider, C.W. Secondary structure of vertebrate telomerase RNA. Cell 100 (2000) 503-514.
• 21. Seto, A.G., Umansky, K., Tzfati, Y., Zang, A.J., Blackburn, E.H. and Cech, T.R. A template-proximal RNA paired elements contributes to saccharomyces cerevisiae telomerase activity. RNA 9 (2003) 1323-1332.
• 22. Mitchell, J.R., Cheng, J. and Collins, K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3’end. Mol. Cell. Biol. 19 (1999) 567-576.
• 23. Chen, J.L., Blasc, M.A. and Greider, C.W. Secondary structure of vertebrate telomerase RNA. Cell 100 (2000) 503-514.
• 24. Mitchell, J.R. and Collins, K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol. Cell. 6 (2000) 361-371.
• 25. Matera, A.G., Terns, R.M. and Terns, M.P. Non-coding RNA: lessons from the small nuclear and small nucleolar RNA. Nat. Rev. Mol. Cell. Biol. 8 (2007) 209-220.
• 26. Dragon, F., Pogacic. V. and Filipowicz, W. In vitro assembly of human H/ACA small nucleolar ribonucleoproteins reveals unique features of U17 and telomerase RNA. Mol. Cell. Biol. 20 (2000) 3037-3048.
• 27. Pogacic, V., Dragon, F. and Filipowicz, W. Human H/ACA small nucleolar ribonucleoproteins and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell. Biol. 20 (2000) 9028-9040.
• 28. Zhu, Y., Tomlinson, R.L., Lukowiak, A.A., Terns, R.M. and Terns, M.P. Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol. Biol. Cell. 15 (2004) 81-90.
• 29. Cristofari, G., Adolf, E., Reichenbach, P., Sikora, K., Terns, R.M., Terns, M.P. and Lingner, J. Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol. Cell. 27 (2007) 882-889.
• 30. Zhang, Q., Kim, N.K. and Feigon, J. Architecture of human telomerase RNA. Proc. Natl. Acad. Sci. 108 (2011) 20325-20332.
• 31. Lendvay, T.S., Morris, D.K., Sah, J., Balasubramanian, B. and Lundblad, V. Senescence mutants of Sachharomyces cerevisiae with a defect in telomerase replication identify three additional EST genes. Genetics 144 (1996) 1399-1412.
• 32. Wick, M., Zubov, D. and Hagen, G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232 (1999) 97-106.
• 33. Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V. and Cech, T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276 (1997) 561-567.
• 34. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B. and Cech, T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959.
• 35. Gillis, A.J., Schuller, A.P. and Skordalakes, E. Structure of the Tribolium castaneum telomerase catalytic subunit TERT. Nature 455 (2008) 633-637.
• 36. Mitchell, M., Gillis, A., Futahashi, M., Fujiwara, H. and Skordalakes, E. Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA. Nature Struct. Mol. Biol. 17 (2010) 513-518.
• 37. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E. Extension of lifespan by introduction of telomerase in to normal human cells. Science 279 (1998) 349-352.
• 38. Cayuela, M.L., Flores, J.M. and Blasco, M.A. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep. 6 (2005) 268-274.
• 39. Canela, A., Martin-Caballero, J., Flores, J.M. and Blasco, M.A. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol. Cell. Biol. 24 (2004) 4275-4293.
• 40. Engelhardt, M., Drullinsky, P., Guillem, J. and Moore, M.A. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3 (1997) 1931-1941.
• 41. Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. and Oda, K. Cooperative of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1 Biochem. Biophys. Res. Commun. 179 (1991) 528-534.
• 42. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B. and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11 (1992) 1921-1929.
• 43. Shay, J.W. and Wright, W.E. Quantitaion of the frequency of immortalization of normal human diploid fibroblasts by sv 40 large T-antigen. Exp. Cell Res. 184 (1989) 109-118.
• 44. Zhu, J., Wang, H., Bishop, J.M. and Blackburn, E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96 (1999) 3723-3728.
• 45. Ding, D., Zhou. J., Wang, M. and Cong, Y. Implications of telomereindependent activities of telomerase reverse transcriptase in human cancer. FEBS J. 280 (2013) 3205-3211.
• 46. Kim, M., Xu, L. and Blackburn, E.H. Catalytically active human telomerase mutants with allele-specific biological properties. Exp. Cell. Res. 288 (2003) 277-287.
• 47. Kenkichi, M., Possemato, R., Wong, J.M., Currier, J.L., Tothova, Z., Manola, J.B., Ganesan, S., Lansdorp, P.M., Collins, K. and Hahn, W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 102 (2005) 8222-8227.
• 48. Stampfer, M.R., Garbe, J., Levine, G., Lichtsteiner, S., Vasserot, A.P. and Yaswen, P. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A (−) human mammary epithelial cells. Proc. Natl. Acad. Sci. USA 98 (2001) 4498-4503.
• 49. Lindvall, C., Hou, M., Komurasaki, T., Zheng, C., Henriksson, M., Sedivy, J.M., Bjorkholm, M., Teh, B.T., Nordenskjold, M. and Xu, D. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res. 63 (2003) 1743-1747.
• 50. Choi, J., Southworth, L.K., Sarin, K.Y., Venteicher, A.S., Ma, W., Chang, W., Cheung, P., Jun, S., Artandi, M.K., Shah, N., Kim, S.K. and Artandi, S.E. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt related developmental program. PLoS Genet. 4 (2008) e10.
• 51. VanMater, D., Kolligs, F.T., Dlugosz, A.A. and Fearon, E.R. Transient activation of beta-catenin signaling in cutaneous keratinocytesis sufficient to trigger the active growth phase of the hair cycle in mice. Genes Dev. 17 (2003) 1219-1224.
• 52. Reya, T. and Clevers, H. Wnt signaling in stem cells and cancer. Nature 434 (2005) 843-850.
• 53. Wege, H., Heim, D., Lütgehetmann, M., Dierlamm, J., Lohse, A.W. and Brümmendorf, T.H. Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes. Mol. Cancer Res. 9 (2011) 1222-1231.
• 54. Chiodi, I. and Mondello, C. Telomere-independent function of telomerase in nuclei, cytoplasm, and mitochondria. Front. Oncol. 2 (2012) 1-6. 55. Rao, T.P. and Ku’hl, M. An updated overview on Wnt signaling pathways: a prelude for more. Circ. Res. 106 (2010) 1798-1806.
• 56. Komiya, Y. and Habas, R. Wnt signal transduction pathways. Organogenesis 4 (2008) 68-75.
• 57. Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M. and Clevers, H. The chromatin remodeling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J. 20 (2001) 4935-4943.
• 58. Surendran, K. and Simon, T.C. CNP gene expression is activate by Wnt signaling and correlates with Wnt4 expression during renal injury. Am. J. Physiol. Renal Physiol. 284 (2003) F653-F662.
• 59. Jho, E., ZhanDomon, C., Joo, C.K., Freund, J.N. and Costantini, F. Wnt/ β - catenin/Tcf signaling induces the transcription of Axin2 a negative regulator of the signaling pathway. Mol. Cell. Biol. 22 (2002) 1172-1183.
• 60. Katoh, M and Katoh, M. Integrative genomic analyses of WNT11: Transcriptional mechanisms based on canonical WNT signals and GATA transcription factors. Int. J. Mol. Med. 24 (2009) 247-251.
• 61. Park, J.I., Venteicher, A.S., Hong, J.Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., McLaughlin, M., Veenstra, T.D., Nusse, R., McCrea, P.D. and Artandi S.E. Telomerase modulates Wnt signaling by association with target gene chromatin. Nature 460 (2009) 66-72.
• 62. Shkreli, M., Sarin, K.Y., Pech, M.F., Papeta, N., Chang, W., Brockman, S.A., Cheung, P., Lee, E., Kuhner, F., Olson, J.L., Kuo, C.J., Gharavi, A.G., D, Agati, V.D. and Artandi, S.E. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat. Med. 18 (2012) 111-119.
• 63. Hoffmeyer, K., Raggioli, A., Rudloff, S., Anton, R., Hierholzer, A., Valle, I.D., Hein, K., Vogt, R. and Kemler, R. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336 (2012) 1549-1554.
• 64. Zhang, Y., Toh, L.L., Lau, P. and Wang, P. Telomerase reverse transcriptase (TERT) is an ovel target of Wnt/β-catenin pathway in human cancer. J. Biol. Chem. 287 (2012) 32494-32511.
• 65. Maida, Y. and Masutomi, K. RNA-dependent RNA polymerases in RNA silencing. Biol. Chem. 392 (2011) 299-304.
• 66. Maida, Y., Yasukawa, M., Furuuchi, M., Lassmann, T., Possemato, R., Okamoto, N., Kasim, V., Hayashizaki, Y., Hahn, W.C. and Masutomi, K. An RNA- dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461 (2009) 230-235.
• 67. Ridanpaa, M., Eenennaam, H., Pelin, K., Chadwick, R., Johnson, C., Yuan, B., Venrooij, W., Pruijn, G., Salmela, R., Rockas, S., Kitie, O.M., Kaitila, I. and Chapelle, A. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104 (2001) 195-203.
• 68. Mukherjee, S., Firpo, E.J., Wang, Y. and Roberts, J.M. Separation of telomerase functions by reverse genetics. Proc. Natl. Acad. Sci. USA 108 (2011) E1363-E1371.
• 69. Santos, J.H., Meyer, J.N., Skorvaga, M., Annab, L.A. and VanHouten, B. Mitochondrial hTERT exacerbates free-radical- mediated mtDNA damage. Aging Cell 3 (2004) 399-411.
• 70. Santos, J.H., Meyer, J.N. and Van Houten, B. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide- induced mitochondrial DNA damage and apoptosis. Hum. Mol. Genet. 15 (2006) 1757-1768.
• 71. Haendeler, J., Hoffmann, J., Rahman, S., Zeiher, A.M. and Dimmeler, S. Regulation of telomerase activity and anti-apoptotic function by proteinprotein interaction and phosphorylation. FEBS Lett. 536 (2003) 180-186.
• 72. Sharma, N.K., Reyes, A., Green, P., Caron, M.J., Bonini, M.G., Gordon, D.M., Holt, I.J. and Santos, J.H. Human telomerase acts as a hTRindependent reverse transcriptase in mitochondria. Nucleic Acids Res. 40 (2012) 712-725.
• 73. Haendeler, J., Hoffmann, J., Diehl, J.F., Vasa, M., Spyridopoulos, I., Zeiher, A.M. and Dimmeler, S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 94 (2004) 768-775.
• 74. Zhang, P., Chan, S.L., Fu, W., Mendoza, M. and Mattson, M.P. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J. 17 (2003) 767-769.
• 75. Massard, C., Zermati, Y., Pauleau, A.L., Larochette, N., Metivier, D., Sabatier, L., Kroemer, G. and Soria, J.C. hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 25 (2006) 4505-4514.
• 76. Lee, J., Sung., Y.H., Cheong, C., Choi, Y.S., Jeon, H.K., Sun, W., Hahn, W.C., Ishikawa, F., and Lee, H.W. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 27 (2008) 3754-3760.
• 77. Ray, S., Karamysheva, Z., Wang, L., Shippen, D.E. and Price, C.M. Interactions between telomerase and primase physically link the telomere and chromosome replication machinery. Mol. Cell. Biol. 22 (2002) 5859-5868.
• 78. Sharma, G.G., Gupta, A., Wang, H., Scherthan, H., Dhar, S., Gandhi, V., Iliakis, G., Shay, J.W., Young, C.S. and Pandita, T.K. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22 (2003) 131-146.
• 79. Sharma, G.G., Hwang, K.K., Pandita, R.K., Gupta, A., Dhar, S., Parenteau, J., Agarwal, M., Worman, H.J. and Wellinger R.J. Human heterochromatin protein 1 isoforms HP1 (Hsalpha) and HP1 (Hsbeta) interfere with hTERTtelomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol. Cell. Biol. 23 (2003) 8363-8376.
• 80. Shin, K.H., Kang, M.K., Dicterow, E., Kameta, A., Baluda, M.A. and Park, N.H. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin. Cancer Res. 10 (2004) 2551-2560.
• 81. Smith, L.L., Coller, H.A. and Roberts, J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell. Biol. 5 (2003) 474-479.

Uwagi

rekord w opracowaniu